German

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

Retrieved on: 
Tuesday, March 12, 2024

Mainz Biomed’s showcase at the UDH Congress underscores the Company’s dedication to bridging the latest in scientific research with the wide spectrum of healthcare practices.

Key Points: 
  • Mainz Biomed’s showcase at the UDH Congress underscores the Company’s dedication to bridging the latest in scientific research with the wide spectrum of healthcare practices.
  • ColoAlert®, Mainz Biomed’s flagship product, is a testament to the Company’s mission, providing a highly accurate, easy-to-use, at-home colorectal cancer (CRC) screening kit.
  • By presenting ColoAlert® at the UDH Congress, Mainz Biomed highlights the role of cutting-edge molecular diagnostics in enhancing comprehensive health strategies, demonstrating the synergy between technological innovation and patient-centric care.
  • For more details on Mainz Biomed’s participation in the UDH Congress and to learn about the Company’s innovative diagnostic solutions, please visit Mainz Biomed’s official website at mainzbiomed.com.

Advent Technologies Signs Strategic Joint Development Agreement with Siemens Energy to Expedite the Decarbonization of the Maritime Sector

Retrieved on: 
Thursday, April 4, 2024

Advent Technologies Holdings, Inc., an innovation-driven leader in the fuel cell and hydrogen technology sectors, is pleased to announce that its wholly owned subsidiary, Advent Technologies A/S (“Advent”), has signed a Joint Development Agreement (“JDA”) with Siemens Energy, one of the world's leading energy technology companies.

Key Points: 
  • Advent Technologies Holdings, Inc., an innovation-driven leader in the fuel cell and hydrogen technology sectors, is pleased to announce that its wholly owned subsidiary, Advent Technologies A/S (“Advent”), has signed a Joint Development Agreement (“JDA”) with Siemens Energy, one of the world's leading energy technology companies.
  • The innovative clean energy solution resulting from this multi-year collaboration is expected to initially address the power needs of large yachts.
  • This agreement builds upon the strong collaboration between Advent and Siemens Energy, which began in February 2022 with the Sanlorenzo Life Ocean pilot project.
  • Advent Technologies' HT-PEM fuel cells utilizing the innovative Ion Pair™ MEA technology, offer high-temperature operation between 80°C and 240°C.

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

Retrieved on: 
Friday, March 22, 2024

Titled "Shaping the Future of Kidney Care," the report provides detailed information about Fresenius Medical Care's economic, social and environmental performance in 2023.

Key Points: 
  • Titled "Shaping the Future of Kidney Care," the report provides detailed information about Fresenius Medical Care's economic, social and environmental performance in 2023.
  • Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care AG, said: "The year 2023 was a transformative one for Fresenius Medical Care, as we set out to achieve important structural, operational, and cultural changes.
  • The 2023 Annual Report summarizes Fresenius Medical Care's steps to successfully deliver on the transformation and contains Fresenius Medical Care's Non-financial Group Report, providing a comprehensive overview of its progress of sustainability activities and achievements in three strategic focus areas:
    Enhancing quality care and access to health care: In about 4,000 dialysis clinics in around 50 countries worldwide, Fresenius Medical Care provided care for over 332,000 patients in 2023.
  • It is available for download as pdf-file on the company's website: Annual reports | Fresenius Medical Care .

EQS-News: IBU-tec Advances Development in Sodium-Ion Battery Research Making Further Progress

Retrieved on: 
Wednesday, March 13, 2024

Among other things, IBU-tec is currently making progress in expanding production towards larger volumes and is pushing ahead with research projects.

Key Points: 
  • Among other things, IBU-tec is currently making progress in expanding production towards larger volumes and is pushing ahead with research projects.
  • IBU-tec has already successfully completed the development and production of phase-pure cathode active material made of sodium manganese layer oxide.
  • In the next step of the research project, IBU-tec is testing the cycle stability of the cathode in full cells and further optimizing it.
  • Ulrich Weitz, Managing Director of IBUvolt battery materials: "With the further development of innovative battery materials, we are securing the future viability of IBU-tec.

EQS-News: After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024

Retrieved on: 
Wednesday, March 13, 2024

After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024

Key Points: 
  • After its second-best financial year in 2023, flatexDEGIRO is aiming for a record year in 2024
    The issuer is solely responsible for the content of this announcement.
  • Frank Niehage, CEO of flatexDEGIRO: "We can be justifiably proud of what we have achieved as a team at flatexDEGIRO over the past few months.
  • At the same time, flatexDEGIRO significantly reduced its marketing expenses by 30.4 percent to EUR 34.0 million in 2023 (2022: EUR 48.9 million).
  • From 2024, flatexDEGIRO will therefore dispense with adjustments in order to establish simpler and more transparent key figures.

EQS-News: Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

Retrieved on: 
Wednesday, March 13, 2024

Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations

Key Points: 
  • Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
    The issuer is solely responsible for the content of this announcement.
  • Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovations
    BERKELEY, US – MAINZ, Germany – March 12th 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a leader in molecular genetics diagnostic solutions for early cancer detection, is proud to announce its upcoming participation at the 39th UDH Congress 2024, taking place on March 16th & 17th in Fellbach, Germany.
  • Mainz Biomed’s showcase at the UDH Congress underscores the Company’s dedication to bridging the latest in scientific research with the wide spectrum of healthcare practices.
  • For more details on Mainz Biomed’s participation in the UDH Congress and to learn about the Company’s innovative diagnostic solutions, please visit Mainz Biomed’s official website at mainzbiomed.com .

EQS-News: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Wednesday, March 13, 2024

The highly encouraging results demonstrated clear separation from placebo in serum neurofilament light chain (NfL) levels in patients with progressive multiple sclerosis (PMS).

Key Points: 
  • The highly encouraging results demonstrated clear separation from placebo in serum neurofilament light chain (NfL) levels in patients with progressive multiple sclerosis (PMS).
  • The results demonstrated meaningful improvements over placebo in four key dimensions of celiac disease pathophysiology: histology, disease symptoms, biomarkers and nutrient absorption.
  • Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access.
  • An archived replay of the webcast will be available approximately one hour after completion on Immunic’s website at: ir.imux.com/events-and-presentations .

EQS-News: P&P London acquires another property in the sought-after Notting Hill district of the British capital and uses the great potential of its prime location with a luxury refurbishment

Retrieved on: 
Wednesday, March 13, 2024

P&P London has announced the acquisition of yet another prime property in the heart of London, adding to its rapidly expanding development portfolio.

Key Points: 
  • P&P London has announced the acquisition of yet another prime property in the heart of London, adding to its rapidly expanding development portfolio.
  • This property, located in the prestigious Notting Hill area within the Royal Borough of Kensington and Chelsea, boasts around 5000 square feet of net living space.
  • A stunning, spacious family home,
    Michael Peter, the founder, and Managing Director of P&P London, elaborates, "The refurbishment will allow us to fully unlock the potential of this property."
  • Established in 2023 as a subsidiary of the German P&P Group, P&P London focuses exclusively on investments within the British capital.

EQS-News: German brand SMARTments connect opens its first property in Frankfurt featuring serviced apartments for young professionals and community kitchens

Retrieved on: 
Wednesday, March 13, 2024

Yesterday, Wednesday, in Germany the first building of the new SMARTments connect serviced apartment brand opened in Frankfurt´s City-East.

Key Points: 
  • Yesterday, Wednesday, in Germany the first building of the new SMARTments connect serviced apartment brand opened in Frankfurt´s City-East.
  • The GBI Group's new product line brings 128 serviced apartments, with communal kitchens on all six floors, to Borsigallee 9, aimed at young professionals, tourists and anyone who likes to mix with others.
  • Guests staying in these apartments also have the opportunity to use the communal kitchens.
  • This combines serviced apartments with other types of property use, including those from the SMARTments family.

Advent Technologies Participates in $12.4 Million Project to Reduce GHG Emissions in the Maritime Sector

Retrieved on: 
Tuesday, March 5, 2024

This project aims to develop a maritime fuel cell system resulting in an auxiliary power unit with a total capacity exceeding 500kW.

Key Points: 
  • This project aims to develop a maritime fuel cell system resulting in an auxiliary power unit with a total capacity exceeding 500kW.
  • The RiverCell 3 project has a total budget of approximately $12.4 million, from which Advent’s budgeted portion is approximately $6.1 million.
  • The project commenced in January 2024 and is scheduled to conclude on December 31, 2026.
  • This strategy aims to mitigate greenhouse gas (“GHG”) emissions for international shipping, with a reinforced commitment to achieving net-zero emissions by 2050.